VISITAS RECIENTES

AUTISMO TEA PDF

AUTISMO TEA PDF
TRASTORNO ESPECTRO AUTISMO y URGENCIAS PDF

We Support The Free Share of the Medical Information

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Enlaces PDF por Temas

Nota Importante

Aunque pueda contener afirmaciones, datos o apuntes procedentes de instituciones o profesionales sanitarios, la información contenida en el blog EMS Solutions International está editada y elaborada por profesionales de la salud. Recomendamos al lector que cualquier duda relacionada con la salud sea consultada con un profesional del ámbito sanitario. by Dr. Ramon REYES, MD

Niveles de Alerta Antiterrorista en España. Nivel Actual 4 de 5.

Niveles de Alerta Antiterrorista en España. Nivel Actual 4 de 5.
Fuente Ministerio de Interior de España

viernes, 1 de mayo de 2026

TRAUMA PENETRANTE DE CUELLO



💥⚖️ TRAUMA PENETRANTE DE CUELLO

DE LAS ZONAS A LA FISIOLOGÍA: INTEGRACIÓN ATLS, TCCC Y PFC (2026)

By DrRamonReyesMD

🧠 CAMBIO DOCTRINAL CLAVE

El paradigma clásico basado en zonas anatómicas (I, II, III) ha sido superado por un enfoque moderno centrado en:

👉 FISIOLOGÍA DEL PACIENTE + IMAGEN

Transición crítica:

  • ❌ “La zona decide” → obsoleto
  • ✅ “La clínica y la estabilidad deciden” → estándar actual

Alineado con:

  • (ATLS)
  • (TCCC)
  • (PFC)

🔴 SIGNOS DUROS = CIRUGÍA INMEDIATA

Representan patología letal en curso:

  • Compromiso de vía aérea (estridor, obstrucción, sangrado masivo)
  • Hematoma en expansión
  • Inestabilidad hemodinámica (shock)
  • Hemorragia arterial activa
  • Soplo o frémito (fístula AV)
  • Déficit neurológico focal

👉 Consenso absoluto:

QUIRÓFANO SIN DEMORA (control de daños)

🟡 SIGNOS BLANDOS = IMAGEN OBLIGATORIA

  • Disfagia / odinofagia
  • Disfonía
  • Hematoma estable
  • Trayecto sospechoso
  • Sangrado leve previo

👉 Punto crítico:

❌ No son indicación quirúrgica inmediata
❌ No permiten observación simple
✅ Requieren estudio con imagen (Angio-TC)

🟢 PACIENTE ESTABLE = “NO-ZONE APPROACH”

📷 ESTÁNDAR ACTUAL: ANGIO-TC (CTA)

Permite:

  • Evaluación vascular (carótida, vertebral)
  • Estudio de vía aerodigestiva
  • Reconstrucción del trayecto lesional

👉 Sustituye la exploración sistemática de zona II

🛠️ MANEJO PREHOSPITALARIO (TCCC)

🔴 ALGORITMO MARCH APLICADO AL CUELLO

M — Hemorragia masiva

  • Compresión directa → PRIORIDAD ABSOLUTA
  • Gasas hemostáticas (packing)
  • Dispositivos de cierre externo (tipo iTClamp)
  • Balón de taponamiento (Foley o comercial)

A — Vía aérea

  • Solo si hay compromiso real
  • ❌ Evitar intubación preventiva innecesaria

R — Respiración

  • Valorar lesión traqueal o torácica asociada

C — Circulación

  • Reanimación de control de daños
  • Ácido tranexámico precoz (si indicado)

H — Hipotermia

  • Prevención obligatoria

🧰 PROLONGED FIELD CARE (PFC)

En escenarios con evacuación retrasada:

  • Reevaluación continua del hematoma
  • Monitorización neurológica seriada
  • Preparación para vía aérea quirúrgica si empeora
  • Repacking o retaponamiento si recidiva el sangrado
  • Evitar manipulación innecesaria

👉 Principio:

“Controlar primero, reevaluar siempre, intervenir solo si es necesario”

🔪 MANEJO QUIRÚRGICO

ABORDAJE ESTÁNDAR

  • Incisión a lo largo del borde anterior del músculo esternocleidomastoideo (ECM)
  • Exposición:
    • Carótida común e interna
    • Yugular interna
    • Nervio vago

EXTENSIONES

  • 🔼 Superior → región submandibular
  • 🔽 Inferior → clavícula / esternotomía parcial

ESCENARIOS COMPLEJOS

  • Lesiones proximales → acceso cervicotorácico combinado
  • Lesiones altas → subluxación mandibular
  • Control difícil → balón o packing dirigido

🧬 MANEJO ENDOVASCULAR

Indicaciones:

  • Lesiones carotídeas o vertebrales seleccionadas
  • Pseudoaneurismas
  • Sangrado controlado en pacientes estables

Ventajas:

  • Menor invasividad
  • Menor morbimortalidad
  • Creciente papel en centros avanzados

⚠️ ERRORES CRÍTICOS

  • ❌ Operar por zona anatómica
  • ❌ Subestimar signos blandos
  • ❌ Observar sin imagen
  • ❌ Sobreindicar vía aérea
  • ❌ Retrasar control hemorrágico

💎 PERLAS CLÍNICAS DE ALTO NIVEL

  • No todo hematoma es quirúrgico → solo el que progresa
  • La estabilidad obliga a estudiar → no tranquiliza
  • La zona orienta → no decide
  • La Angio-TC aumenta precisión → no sustituye al cirujano
  • El error actual → operar sin indicación

📚 REFERENCIAS DOCTRINALES

  • J Trauma Acute Care Surgery (CTA y manejo selectivo)
  • Revisiones vasculares contemporáneas (2024–2026)

🔚 VEREDICTO FINAL 2026

El trauma cervical penetrante ya no es un problema anatómico.
Es un problema fisiológico guiado por imagen.

✔️ Controla la hemorragia primero
✔️ Protege la vía aérea solo si es necesario
✔️ Usa imagen de forma agresiva
✔️ Opera de forma selectiva
✔️ Adapta el manejo al entorno (hospital / táctico / PFC)



PENETRATING NECK TRAUMA ALGORITHM 2026


By DrRamonReyesMD
EMS Solutions International

ESPAÑOL

1) Sospecha de trauma penetrante de cuello

Toda herida que penetra el platisma debe considerarse potencialmente letal hasta demostrar lo contrario. El abordaje inicial sigue la lógica ATLS de amenazas vitales inmediatas, pero en entorno táctico o austero debe integrarse además en MARCH y en los principios de Prolonged Field Care si la evacuación no es inmediata.

2) Control inmediato de hemorragia

Si hay hemorragia externa, la prioridad es compresión directa inmediata. Según el escenario, puede añadirse gasa hemostática, cierre mecánico tipo iTClamp en heridas seleccionadas, y en hemorragias no compresibles seleccionadas puede emplearse taponamiento con balón/Foley como medida temporal hasta el control definitivo. Si se coloca un iTClamp en el cuello, debe vigilarse estrechamente la vía aérea y la posible expansión del hematoma.

3) Vía aérea: intervenir solo cuando está indicada

No toda herida cervical necesita una vía aérea avanzada inmediata. La indicación real aparece ante obstrucción, estridor, sangrado que compromete la ventilación, edema progresivo, hematoma expansivo, lesión laringotraqueal o deterioro clínico. La intubación “preventiva” sin indicación puede empeorar el escenario. En PFC, si la evacuación se retrasa, debe mantenerse preparación para vía aérea definitiva o quirúrgica si la situación evoluciona.

4) Clasificación clínica inicial

Signos duros: compromiso de vía aérea, hematoma en expansión, hemorragia activa importante, shock o inestabilidad hemodinámica, soplo/frémito, déficit neurológico focal. Estos hallazgos obligan a control quirúrgico o intervencionista inmediato según recursos. Signos blandos: disfagia, odinofagia, disfonía, hematoma estable, trayecto sospechoso, sangrado autolimitado. Estos no significan “observación simple”: exigen estudio.

5) Paciente inestable o con signos duros

No retrasar el control definitivo por pruebas innecesarias. En hospital: quirófano o estrategia híbrida según disponibilidad. En entorno táctico o PFC: control temporal, reanimación de control de daños, reevaluación seriada y evacuación prioritaria.

6) Paciente estable sin signos duros

Aplicar enfoque “no-zone”: la localización anatómica orienta, pero ya no decide por sí sola. El estándar moderno es Angio-TC de cuello (CTA) en pacientes estables, porque permite valorar lesión vascular y gran parte de la afectación aerodigestiva, reduciendo exploraciones cervicales no terapéuticas.

7) Hallazgos en imagen y conducta

Si la imagen confirma lesión vascular, aerodigestiva o trayecto de alto riesgo, el manejo pasa a ser quirúrgico, endovascular o combinado, según el tipo de lesión, la fisiología del paciente y la experiencia del centro. El papel del tratamiento endovascular ha crecido especialmente en lesiones carotídeas o vertebrales seleccionadas en pacientes estables.

8) Enfoque PFC/JTS cuando no se puede evacuar rápido

Si el paciente permanece en campo o en una plataforma Role 1 prolongada, el énfasis es: control hemorrágico mantenido, vigilancia del hematoma, reevaluación neurológica seriada, monitorización respiratoria, prevención de hipotermia, reanimación prudente y preparación para empeoramiento brusco de la vía aérea. El principio no es “hacer más”, sino hacer lo necesario, en el momento correcto, con mínima manipulación inútil.

9) Errores frecuentes

Operar por zona II sin más criterio, subestimar signos blandos, observar sin imagen a un paciente estable con trayecto sospechoso, sobreindicar la vía aérea y no controlar primero la hemorragia son errores que el enfoque moderno intenta evitar.

ENGLISH

1) Suspected penetrating neck trauma

Any wound that violates the platysma must be treated as potentially life-threatening until proven otherwise. Initial management follows ATLS priorities, but in tactical or austere settings it must also be integrated into MARCH and Prolonged Field Care principles when evacuation is delayed.

2) Immediate hemorrhage control

If there is external bleeding, direct pressure comes first. Depending on the setting, adjuncts may include hemostatic gauze, mechanical closure such as iTClamp for selected wounds, and Foley/balloon tamponade for selected non-compressible bleeding as a bridge to definitive care. If iTClamp is used on the neck, airway status and hematoma expansion must be monitored closely.

3) Airway: intervene only when indicated

Not every penetrating neck wound requires immediate advanced airway management. The real indications are airway obstruction, stridor, major bleeding affecting ventilation, progressive swelling, expanding hematoma, laryngotracheal injury, or clinical deterioration. “Preventive” intubation without a clear indication may worsen the situation. In PFC, delayed evacuation requires airway contingency planning, including readiness for surgical airway if the patient deteriorates.

4) Initial clinical stratification

Hard signs include airway compromise, expanding hematoma, major active hemorrhage, shock/hemodynamic instability, bruit/thrill, and focal neurologic deficit. These findings mandate immediate operative or interventional control depending on resources. Soft signs include dysphagia, odynophagia, dysphonia, stable hematoma, suspicious trajectory, or minor self-limited bleeding. These are not indications for simple observation; they require workup.

5) Unstable patient or hard signs

Do not delay definitive control with unnecessary imaging. In hospital, proceed to the OR or hybrid strategy as appropriate. In tactical or PFC settings, prioritize temporary control, damage control resuscitation, serial reassessment, and urgent evacuation.

6) Stable patient without hard signs

Use the modern “no-zone” approach: anatomy still guides thinking, but no longer dictates management by itself. The current standard in stable patients is neck CT angiography (CTA), which evaluates vascular injury and much of the aerodigestive tract while reducing non-therapeutic neck explorations.

7) Imaging-based decision making

If CTA identifies vascular, aerodigestive, or otherwise significant injury, management becomes operative, endovascular, or combined, depending on lesion type, patient physiology, and institutional capability. Endovascular management has an increasingly important role in selected stable carotid or vertebral injuries.

8) PFC/JTS perspective when evacuation is delayed

If the casualty remains in the field or at a prolonged Role 1 capability, priorities are sustained hemorrhage control, serial hematoma checks, repeated neurologic reassessment, respiratory monitoring, hypothermia prevention, careful resuscitation, and preparation for sudden airway deterioration. The doctrine is not to “do everything,” but to do the right thing at the right time with minimal unnecessary manipulation.

9) Common errors

Operating solely because the wound is in Zone II, underestimating soft signs, observing a stable patient without imaging despite a concerning trajectory, overusing airway intervention, and failing to control hemorrhage first remain major errors.



  1. American College of Surgeons. Advanced Trauma Life Support (ATLS).
    DOI: sin DOI
    URL: https://www.facs.org/quality-programs/trauma/education/advanced-trauma-life-support/

  2. ACS Store. ATLS Student Course Manual, 10th Edition.
    DOI: sin DOI
    URL: https://store.facs.org/atls-student-course-manual-10th-edition

  3. Western Trauma Association Critical Decisions in Trauma: Penetrating neck trauma. Jason L. Sperry et al. 2013.
    DOI: sin DOI visible en el PDF abierto aquí
    URL: https://www.westerntrauma.org/wp-content/uploads/2020/07/WTACriticalDecisionsPenetratingNeckTrauma.pdf

  4. EAST Practice Management Guideline: Penetrating Zone II Neck Trauma.
    DOI: sin DOI
    URL: https://www.east.org/Content/documents/practicemanagementguidelines/EAST%20PMG_penetrating%20neck_2008.pdf

  5. Inaba K, Branco BC, Menaker J, et al. Evaluation of Multidetector Computed Tomography for Penetrating Neck Injury: A Prospective Multicenter Study.
    DOI: 10.1097/TA.0b013e31824badf7
    URL: https://pubmed.ncbi.nlm.nih.gov/22491539/

  6. Ibraheem K, Wong S, Smith A, et al. Computed Tomography Angiography in the “No-Zone” Approach Era for Penetrating Neck Trauma: A Systematic Review.
    DOI: 10.1097/TA.0000000000002919
    URL: https://pubmed.ncbi.nlm.nih.gov/32890346/

  7. Loss L, Henry R, White A, et al. Penetrating neck trauma: a comprehensive review. Trauma Surgery & Acute Care Open. 2025.
    DOI: 10.1136/tsaco-2024-001619
    URL: https://tsaco.bmj.com/content/10/1/e001619

  8. TCCC Guidelines 2024.
    DOI: sin DOI
    URL: https://learning-media.allogy.com/api/v1/pdf/402c4802-731e-4bb2-8fae-24509e580896/contents

  9. Airway Management in Prolonged Field Care (JTS CPG ID:80).
    DOI: sin DOI
    URL: https://prolongedfieldcare.org/wp-content/uploads/2022/05/All-PFC-CPGs.pdf
    URL alternativa: https://tccc.org.ua/files/downloads/airway-management-in-prolonged-field-care-pcc-en.pdf

  10. Prolonged Casualty Care Guidelines (JTS CPG ID:91).
    DOI: sin DOI
    URL: https://jts.health.mil/assets/docs/cpgs/Prolonged_Casualty_Care_Guidelines_21_Dec_2021_ID91.pdf

  11. Tan ECTH, Peters JH, McKee JL, Edwards MJR. The iTClamp in the management of prehospital haemorrhage.
    DOI: 10.1016/j.injury.2015.12.017
    URL: https://pubmed.ncbi.nlm.nih.gov/26772450/

  12. Navsaria P, Thoma M, Nicol A. Foley Catheter Balloon Tamponade for Life-threatening Hemorrhage in Penetrating Neck Trauma.
    DOI: 10.1007/s00268-005-0538-3
    URL: https://onlinelibrary.wiley.com/doi/10.1007/s00268-005-0538-3

Firma final

DrRamonReyesMD
EMS Solutions International


Posted by at No hay comentarios:

GLOVE COLORS IN MEDICINE, EMS, TACMED, LABORATORY AND HOSPITAL SETTINGS



GLOVE COLORS IN MEDICINE, EMS, TACMED, LABORATORY AND 

HOSPITAL SETTINGS: WHAT ACTUALLY MATTERS AND WHAT IS NOISE

DrRamonReyesMD | EMS Solutions International

There are debates born from science, and there are debates born from the market. The discussion about glove color—except for very specific nuances—belongs far more to the latter than to the former.

The issue is not acknowledging that color may have some perceptual, logistical, or organizational value. The issue is inflating it into a major determinant of biosafety, clinical performance, or operational effectiveness. That position is not supported by the real hierarchy of evidence nor by the operational logic of serious work in medicine, emergency care, laboratory science, or tactical medicine.

THE CORE PRINCIPLE: A GLOVE IS A BARRIER DEVICE

A medical glove is fundamentally a barrier device.

Its purpose is not:

  • To “look good”
  • To “provide visual contrast”
  • To “project a tactical image”

Its purpose is:

  • To reduce exposure to blood
  • Body fluids
  • Secretions and excretions
  • Mucous membranes
  • Non-intact skin
  • Potentially contaminated materials

Regulatory frameworks reflect this reality.

The U.S. FDA regulates medical gloves focusing on:

  • Acceptable Quality Level (AQL)
  • Defect rates
  • Physical resistance
  • Manufacturing consistency
  • Biocompatibility
  • Design control

Not on color.

In fact, adding color is considered a formulation change, requiring documentation—because color is an additive, not a performance-enhancing property.

FIRST DEMOLITION: COLOR IS NOT A PRIMARY SAFETY VARIABLE

Color is not a primary determinant of safety.

A high-quality glove can be:

  • Blue
  • Black
  • Purple
  • Any other color

A poor-quality glove can be exactly the same colors.

If the glove:

  • Tears during donning
  • Has manufacturing defects
  • Shows batch inconsistency
  • Has degraded due to heat
  • Has lost elasticity
  • Contains microfailures

Then all color-based arguments collapse instantly.

WHAT ACTUALLY MATTERS: MATERIAL SCIENCE AND PERFORMANCE

When the discussion becomes serious, it moves to materials:

Nitrile

  • High mechanical resistance
  • Good chemical resistance
  • No natural latex proteins → reduced allergy risk
  • Current dominant standard in EMS and healthcare

Latex

  • Superior elasticity
  • High tactile sensitivity
  • Significant allergy risk (Type I hypersensitivity)

Vinyl

  • Inferior barrier performance under stress
  • Higher failure rates in use
  • Limited role in low-risk scenarios

👉 This is real science.
👉 This determines protection—not color.

FENTANYL PERMEATION, STORAGE AND REAL-WORLD CONDITIONS

Recent data show that:

  • Glove stretching
  • Storage temperature

can significantly alter barrier performance (e.g., fentanyl permeation studies).

This is operationally critical for:

  • Ambulances
  • Tactical kits
  • Backpacks
  • Vehicles exposed to heat/cold

👉 This matters.
👉 Color does not.

WHERE COLOR HAS LIMITED, VALID VALUE

To be precise and intellectually honest:

Color can have secondary roles:

Hospital / EMS

  • Visual standardization
  • Stock management
  • Rapid recognition

TACMED / Low-light operations

  • Black gloves → reduced visual signature
  • Uniformity within team

Laboratory / Hazard control

  • Internal coding systems
  • Task segregation

But:

Color does NOT increase biological protection, mechanical resistance, or clinical effectiveness.

THE BLACK GLOVE MYTH (TACTICAL CONTEXT)

Black gloves may be:

  • Operationally coherent
  • Visually discreet
  • Organizationally consistent

But:

They are NOT superior in barrier protection.

Any claim of universal clinical superiority of black gloves is propaganda, not doctrine.

THE BLUE GLOVE MYTH (CLINICAL CONTEXT)

Blue gloves:

  • Are widely used
  • Are culturally associated with healthcare

But:

There is NO regulatory or scientific basis declaring blue superior due to “blood contrast”.

A high-quality glove remains high-quality independent of pigment.

THE PURPLE GLOVE MISCONCEPTION (CHEMOTHERAPY)

Purple gloves are often associated with chemotherapy handling.

However:

Color does not certify protection.

What matters is compliance with standards such as:

  • ASTM D6978 (chemotherapy drug permeation resistance)

Selection must be based on:

  • Tested resistance
  • Manufacturer documentation
  • Chemical compatibility

Not visual assumptions.

THE “COLOR HELPS IDENTIFY BLOOD” FALLACY

This argument collapses under real operational conditions.

In:

  • Prehospital care
  • Tactical environments
  • Low-light settings
  • Contaminated scenes

You do NOT rely primarily on visual contrast.

You rely on:

  • Tactile detection (wetness, warmth)
  • Tissue disruption
  • Anatomical source
  • Bleeding pattern
  • Mechanism of injury

The TCCC Tactical Trauma Assessment Guide explicitly promotes:

  • Blood sweep
  • Systematic search (neck, axillae, groin, extremities)

👉 This is tactile, rapid, and operational—not aesthetic.

REAL BIOSAFETY: CDC AND WHO POSITION

CDC

Gloves are indicated when anticipating:

  • Blood exposure
  • Body fluids
  • Mucosa
  • Non-intact skin
  • Contaminated equipment

Must be:

  • Changed between contaminated → clean areas
  • Followed by hand hygiene

WHO (2025)

  • Gloves reduce risk
  • BUT do NOT replace hand hygiene
  • Gloves become contaminated like bare hands

👉 Critical takeaway:

Gloves are not a talisman.
Color does not change contamination risk.

RATIONAL GLOVE USE (CLINICAL MATURITY)

Not every intervention requires gloves.

Overuse:

  • Reduces dexterity
  • Impairs tactile sensitivity
  • Wastes resources

Proper practice:

  • Indication-based use
  • Not ritualistic use

TACTILE MEDICINE: STILL RELEVANT

Finger pulp sensitivity allows detection of:

  • Crepitus
  • Fluctuance
  • Temperature gradients
  • Subcutaneous emphysema
  • Tissue discontinuity

This requires:

  • Proper glove selection
  • Or no glove when not indicated

THE ONLY STRONGLY SUPPORTED ADVANTAGE: DOUBLE GLOVING

Evidence (Cochrane and subsequent studies):

  • Double gloving reduces inner glove perforation
  • Indicator systems improve detection of outer glove rupture

👉 This is real, evidence-based improvement

Not color.

LABORATORY AND HAZARDOUS DRUG HANDLING

Critical factors:

  • Chemical compatibility
  • Permeation resistance
  • Cuff length
  • Replacement timing
  • Regulatory compliance

Color = secondary, organizational only.

REAL HIERARCHY OF GLOVE SELECTION

  1. Indication
  2. Manufacturing quality
  3. Material selection
  4. Barrier integrity
  5. Fit and dexterity
  6. Storage conditions
  7. Replacement timing + hand hygiene
  8. Color (optional, organizational)

FINAL CONCLUSION

Color may have:

  • Minor operational value
  • Organizational usefulness

But:

It is NOT a determinant of biosafety.

The real threats are:

  • Poor-quality gloves
  • Degraded materials
  • Wrong glove for the task
  • Incorrect use

SIGNED POSITION

As an emergency and trauma physician with operational experience across hospital, prehospital, tactical, austere, and remote environments:

Glove color is peripheral. Barrier integrity is everything.

In serious medicine, serious EMS, serious TACMED, and serious biosafety:

Barrier first. Everything else is secondary.

REFERENCES (VERIFIED – NO FABRICATION)

Regulatory & Guidelines

Evidence & Studies

Tactical & Operational Doctrine

Chemical Safety

Occupational Exposure (Fentanyl Study)



Posted by at No hay comentarios:

Cuánto tarda una ambulancia en España y por qué el desfibrilador marca la diferencia by DrRamonReyesMD

 


Cuánto tarda una ambulancia en España y por qué el desfibrilador marca la diferencia

Artículo científico actualizado 2026

By DrRamonReyesMD ⚕️

La parada cardiorrespiratoria extrahospitalaria (PCREH) constituye una de las emergencias médicas más tiempo-dependientes de la práctica clínica. En este contexto, la pregunta “cuánto tarda una ambulancia” trasciende lo logístico y se convierte en una cuestión de fisiopatología cerebral, perfusión tisular y supervivencia neurológica. El artículo original que aportas es correcto en su mensaje divulgativo, pero requiere una revisión técnica: no discrimina entre tipos de tiempo de respuesta, no contextualiza la variabilidad territorial y no incorpora evidencia científica estructurada con referencias verificables.

En España, los datos disponibles más consistentes sitúan el tiempo medio de respuesta de los servicios de emergencias médicas en torno a 11 minutos para parada cardiorrespiratoria, con variaciones según entorno urbano o rural, densidad de recursos y modelo organizativo autonómico. Este dato procede de análisis poblacionales y del informe EuReCa difundido por organismos como el Consejo Español de Resucitación Cardiopulmonar y entidades como Fundación MAPFRE. Además, únicamente alrededor del 23–25 % de los pacientes reciben asistencia en menos de 8 minutos, lo que tiene implicaciones directas sobre la supervivencia.
URL: https://www.fundacionmapfre.org/sala-de-prensa/paradas-cardiorespiratorias/

Este intervalo debe interpretarse correctamente. En medicina de emergencias, el “tiempo de respuesta” puede referirse al tiempo desde la llamada al centro coordinador hasta la llegada del primer recurso, pero no necesariamente coincide con el tiempo hasta la primera intervención efectiva. Asimismo, no es equivalente una ambulancia de soporte vital básico (SVB) que una de soporte vital avanzado (SVA), ni una parada presenciada en vía pública con DEA disponible que una parada no presenciada en domicilio rural.

Desde el punto de vista epidemiológico, la PCREH representa un problema sanitario de gran magnitud. En Europa y Estados Unidos se estiman entre 350.000 y 400.000 casos anuales, con tasas de supervivencia global en torno al 10 %, con variabilidad significativa entre sistemas sanitarios. En España, el registro OHSCAR (Out-of-Hospital Spanish Cardiac Arrest Registry) ha permitido analizar de forma sistemática estos eventos, incluyendo datos de 18 servicios de emergencias que cubren más de 44 millones de habitantes.
Referencia: Ruiz Azpiazu JI et al. Emergencias 2024;36:131–139
URL: https://revistaemergencias.org/wp-content/uploads/2024/03/131-139.pdf

La comprensión del impacto del tiempo exige analizar la fisiopatología de la parada cardíaca. En ausencia de actividad mecánica eficaz, el gasto cardíaco se reduce a cero, la presión de perfusión cerebral desaparece y el tejido neuronal entra en isquemia global. El cerebro, especialmente estructuras como el hipocampo, presenta una tolerancia extremadamente limitada a la hipoxia. La lesión neuronal comienza en minutos y progresa rápidamente si no se restablece flujo sanguíneo.

En los primeros minutos, muchos pacientes presentan ritmos desfibrilables, principalmente fibrilación ventricular (FV) o taquicardia ventricular sin pulso (TVSP). En esta fase existe una ventana terapéutica en la que la desfibrilación puede revertir el caos eléctrico miocárdico. A medida que transcurre el tiempo sin intervención, el miocardio se acidifica, se agotan las reservas energéticas y el ritmo evoluciona hacia asistolia, donde la desfibrilación deja de ser efectiva.

El desfibrilador externo automatizado (DEA) no “reinicia el corazón” en sentido literal. Su función es analizar el ritmo y, si detecta FV o TVSP, administrar una descarga eléctrica no sincronizada que despolariza simultáneamente el miocardio, permitiendo la recuperación de un ritmo organizado. No actúa en asistolia ni en actividad eléctrica sin pulso.

La evidencia científica demuestra de forma consistente que la desfibrilación precoz mejora de manera significativa la supervivencia. El ensayo clínico de Hallstrom et al., publicado en The New England Journal of Medicine, mostró que la combinación de RCP y DEA en entornos comunitarios duplicaba aproximadamente la supervivencia frente a RCP sola.
DOI: 10.1056/NEJMoa040566
URL: https://pubmed.ncbi.nlm.nih.gov/15306665/

Revisiones sistemáticas posteriores han confirmado que los programas de desfibrilación de acceso público pueden alcanzar tasas de supervivencia cercanas al 40 % en escenarios óptimos, especialmente en paradas presenciadas con intervención precoz.
DOI: 10.1161/CIRCULATIONAHA.117.029067
URL: https://www.ahajournals.org/doi/10.1161/circulationaha.117.029067

El concepto crítico es la relación entre tiempo y supervivencia. De forma clásica, se acepta que la probabilidad de supervivencia disminuye aproximadamente 7–10 % por cada minuto sin RCP ni desfibrilación en paradas con ritmo desfibrilable. Aunque esta cifra es una simplificación, sigue siendo útil desde el punto de vista clínico.

La secuencia temporal relevante puede resumirse así: en el primer minuto debe reconocerse la parada; en los primeros dos minutos debe activarse el sistema de emergencias e iniciarse la RCP; entre los 2 y 5 minutos se encuentra la ventana óptima de desfibrilación; a partir de los 5–8 minutos el pronóstico neurológico empeora de forma significativa; y más allá de los 10–15 minutos la probabilidad de supervivencia sin daño cerebral severo disminuye drásticamente si no ha habido intervención precoz.

Las guías del European Resuscitation Council (ERC) 2025 refuerzan este enfoque. La cadena de supervivencia incluye reconocimiento precoz, RCP inmediata, desfibrilación temprana, soporte vital avanzado y cuidados post-resucitación.
URL: https://www.erc.edu/science-research/guidelines/guidelines-2025/guidelines-2025-english/

En España, uno de los principales problemas es la baja tasa de intervención por testigos. Aunque ha mejorado en los últimos años, la RCP por testigos se sitúa alrededor del 35–40 % en muchos registros, y el uso de DEA sigue siendo limitado en comparación con otros países europeos. Esto genera un desfase entre el inicio de la parada y la primera intervención efectiva, que no puede ser compensado únicamente por la llegada de la ambulancia.

Por tanto, la afirmación central del artículo original es correcta pero debe reformularse con precisión: la ambulancia no es el primer eslabón de la supervivencia en la parada cardíaca. El determinante crítico es lo que ocurre en los primeros minutos, antes de su llegada. El desfibrilador no es un complemento, sino el elemento terapéutico clave en los ritmos desfibrilables durante la fase inicial.

En conclusión, el tiempo medio de respuesta de una ambulancia en España es compatible con estándares europeos, pero resulta fisiológicamente tardío para revertir una parada cardíaca si no ha habido intervención previa. La supervivencia depende de la activación precoz del sistema, de la RCP por testigos y de la disponibilidad y uso temprano del DEA. La diferencia entre la vida y la muerte, en muchos casos, se decide antes de que el recurso sanitario llegue al paciente.



Posted by at No hay comentarios:

jueves, 30 de abril de 2026

SLISHMAN TRACTION SPLINT COMPACT (STS-C) Análisis científico integral, fisiopatológico, biomecánico, neurovascular y doctrinal (TCCC) Actualizado 2026 | By DrRamonReyesMD ⚕️

 

🔬 SLISHMAN TRACTION SPLINT COMPACT (STS-C)

Análisis científico integral, fisiopatológico, biomecánico, neurovascular y doctrinal (TCCC)

Actualizado 2026 | By DrRamonReyesMD ⚕️





🧠 INTRODUCCIÓN — NIVEL REAL

La fractura diafisaria de fémur no es una “lesión ortopédica más”.

Es una lesión sistémica compleja que compromete simultáneamente:

  • Sistema vascular profundo (arteria femoral, ramas perforantes)
  • Sistema nervioso periférico (nervio femoral, ciático en su trayecto proximal)
  • Sistema muscular (cuádriceps, aductores, isquiotibiales)
  • Sistema fascial (compartimentos musculares cerrados)
  • Sistema ligamentoso y estabilidad biomecánica global

👉 Resultado clínico real:

  • Hemorragia interna potencial: 1–2 litros
  • Dolor severo neurogénico + mecánico
  • Riesgo de shock hipovolémico
  • Riesgo de lesión neurovascular secundaria por desplazamiento

🔴 LESIÓN COMPLEJA FEMORAL — ANÁLISIS PROFUNDO

🩸 1. DAÑO VASCULAR

  • Arteria femoral profunda (principal riesgo oculto)
  • Ramas perforantes musculares
  • Hemorragia intracompartimental

👉 Consecuencia:

  • Shock hipovolémico oculto
  • No visible externamente

🧠 2. DAÑO NEUROLÓGICO

  • Nervio femoral → déficit extensión rodilla
  • Nervio ciático (posterior) → déficit distal
  • Plexo lumbar → dolor irradiado

👉 Importante:

❗ La tracción incorrecta puede:

  • Agravar neuropraxia
  • Generar lesión axonal secundaria

💪 3. DAÑO MUSCULAR

  • Cuádriceps → espasmo dominante
  • Isquiotibiales → tracción posterior
  • Aductores → desalineación medial

👉 Resultado:

  • Acortamiento del miembro
  • Dolor extremo
  • Aumento de sangrado por desgarro muscular

🧬 4. SISTEMA FASCIAL

  • Compartimentos cerrados
  • Aumento presión intracompartimental

👉 Riesgo:

  • Síndrome compartimental
  • Isquemia secundaria

🦴 5. COMPONENTE LIGAMENTOSO Y ARTICULAR

  • Inestabilidad global del miembro
  • Pérdida de eje mecánico

⚙️ ¿QUÉ HACE REALMENTE EL STS-C?

👉 Aquí es donde el nivel sube.

El STS no solo “inmoviliza”.

🔴 ACTÚA SOBRE:

✔ Vascular → reduce sangrado
✔ Neurológico → disminuye irritación nerviosa
✔ Muscular → elimina espasmo
✔ Fascial → reduce presión indirectamente
✔ Mecánico → restaura alineación

🧠 MECANISMO REAL DE ACCIÓN

🔬 EFECTO 1 — ALINEACIÓN

  • Restaura longitud femoral
  • Reduce desplazamiento óseo

🩸 EFECTO 2 — HEMOSTASIA INDIRECTA

  • Disminuye espacio muerto muscular
  • Reduce sangrado intramuscular

👉 Relacionado con evidencia general de férulas:

🧠 EFECTO 3 — NEUROPROTECCIÓN FUNCIONAL

  • Reduce tracción sobre nervios
  • Disminuye estímulo nociceptivo

💪 EFECTO 4 — RELAJACIÓN MUSCULAR

  • Elimina espasmo reflejo
  • Reduce consumo metabólico

⚖️ EFECTO 5 — PERFUSIÓN DISTAL

  • Mejora flujo arterial distal
  • Reduce compresión vascular

⚔️ VALIDACIÓN OPERACIONAL (JSOM)

📄 Evaluación comparativa

RESULTADOS CLAVE:

  • Mayor rapidez
  • Mejor control
  • Mejor aceptación operador
  • Mejor rendimiento global

👉 Conclusión:

“Most suitable for battlefield use”

⚙️ COMPARACIÓN DOCTRINAL (ACTUALIZADA)

🔴 STS vs HARE vs SAGER vs KTD

Parámetro STS Hare Sager KTD
Tipo Monopolar proximal Bipolar clásico Central bilateral Modular
Tracción Desde cadera (push) Desde pie (pull) Desde pelvis Desde pie
Compacto ⭐⭐⭐⭐⭐ ⭐ ⭐ ⭐⭐⭐
Tiempo aplicación ⭐⭐⭐⭐⭐ ⭐⭐ ⭐ ⭐⭐⭐
Uso en amputación ✅ ❌ ❌ ❌
Uso en helicóptero ⭐⭐⭐⭐⭐ ⭐ ⭐ ⭐⭐
Complejidad Baja Media Alta Media

⚔️ ANÁLISIS OPERACIONAL REAL

👉 STS resuelve 3 problemas históricos:

  1. Espacio distal
  2. Logística
  3. Trauma complejo

⚔️ INTEGRACIÓN TCCC (MARCH)

🔴 M — Massive Hemorrhage

  • Control externo primero (TQ si necesario)

🔴 C — Circulation

👉 STS aquí:

  • Reduce hemorragia interna
  • Mejora estabilidad hemodinámica

🧠 ERROR CRÍTICO

❌ Aplicar sin control previo de hemorragia
❌ No evaluar pulso distal
❌ No reevaluar estado neurológico

🔴 REEVALUACIÓN OBLIGATORIA (POST-APLICACIÓN)

Después de aplicar STS:

✔ Pulso distal
✔ Relleno capilar
✔ Sensibilidad
✔ Motricidad
✔ Dolor

👉 Si empeora → reducir tracción

⚠️ COMPLICACIONES SI MAL USO

  • Isquemia distal
  • Compresión nerviosa
  • Dolor agravado
  • Lesión vascular secundaria

🧠 NIVEL EXPERTO — LO QUE NADIE DICE

👉 La férula de tracción es uno de los pocos dispositivos que:

  • Interviene en fisiopatología profunda
  • No solo estabiliza, modifica el curso del trauma

👉 Pero:

⚠️ Mal aplicada = daño iatrogénico real

🧾 VEREDICTO FINAL 2026

El STS-C es:

  • Evolución real, no marketing
  • Adaptado a guerra moderna, EMS y entornos austeros
  • Dispositivo con impacto fisiológico directo

👤 PERFIL PROFESIONAL — AUTORIDAD

Dr. Ramón Alejandro Reyes Díaz, MD (DrRamonReyesMD ⚕️)

Médico especialista en:

  • Medicina de Emergencias y Trauma
  • Medicina Táctica (TACMED)
  • Medicina Austera y Remota
  • Medicina Aeromédica y Offshore

Instructor internacional certificado:

  • ATLS, PHTLS, ITLS
  • TCCC, TECC, TCC-LEFR

Experiencia operativa en:

  • Unidades élite militares y policiales
  • Protección de dignatarios (VIP Medicine)
  • Zonas de conflicto (Irak, Malí, Mozambique)

Evaluador internacional independiente de dispositivos médicos:

  • Sin conflictos de interés
  • Sin compromisos comerciales
  • Basado en evidencia y experiencia operativa real

🧠 POSICIÓN FINAL

👉 Este análisis NO es marketing
👉 Es evaluación técnica, clínica y operacional

📚 REFERENCIAS

🧠 FRASE FINAL (NIVEL OPERADOR REAL)

“Una férula de tracción no es para inmovilizar una pierna.
Es para evitar que el paciente muera lentamente por dentro.”

Si quieres el siguiente nivel real:

👉 SOP completo TCCC + checklist unidad + errores en combate real

Eso ya no es artículo.
Eso es doctrina.

Posted by at No hay comentarios:

SLISHMAN TRACTION SPLINT COMPACT (STS-C) Comprehensive scientific, pathophysiological, biomechanical, neurovascular and doctrinal (TCCC) analysis Updated 2026 | By DrRamonReyesMD ⚕️

 

🔬 SLISHMAN TRACTION SPLINT COMPACT (STS-C)

Comprehensive scientific, pathophysiological, biomechanical, neurovascular and doctrinal (TCCC) analysis

Updated 2026 | By DrRamonReyesMD ⚕️

Download PDF




🧠 INTRODUCTION — REAL LEVEL

A femoral shaft fracture is not “just another orthopedic injury.”

It is a complex systemic injury simultaneously involving:

  • Deep vascular system (femoral artery, profunda femoris, perforating branches)
  • Peripheral nervous system (femoral nerve, proximal sciatic nerve pathway, lumbar plexus)
  • Muscular system (quadriceps, adductors, hamstrings)
  • Fascial system (closed muscle compartments)
  • Ligamentous structures and global biomechanical stability

👉 Real clinical outcome:

  • Potential internal hemorrhage: 1–2 liters
  • Severe nociceptive + neuropathic pain
  • Risk of hypovolemic shock
  • Risk of secondary neurovascular injury due to displacement

🔴 COMPLEX FEMORAL INJURY — DEEP ANALYSIS

🩸 1. VASCULAR DAMAGE

  • Profunda femoris artery (primary occult bleeding source)
  • Muscular perforating branches
  • Intracompartmental hemorrhage

👉 Consequence:

  • Hidden hypovolemic shock
  • No external bleeding signs

🧠 2. NEUROLOGICAL DAMAGE

  • Femoral nerve → impaired knee extension
  • Sciatic nerve → distal deficits
  • Lumbar plexus → referred and radiating pain

👉 Critical point:

❗ Improper traction may:

  • Worsen neuropraxia
  • Induce secondary axonal injury

💪 3. MUSCULAR DAMAGE

  • Quadriceps → dominant spasm generator
  • Hamstrings → posterior displacement force
  • Adductors → medial deformity

👉 Outcome:

  • Limb shortening
  • Severe pain
  • Increased bleeding from muscle tearing

🧬 4. FASCIAL SYSTEM

  • Closed compartments
  • Increased intracompartmental pressure

👉 Risk:

  • Compartment syndrome
  • Secondary ischemia

🦴 5. LIGAMENTOUS AND ARTICULAR COMPONENT

  • Global limb instability
  • Loss of mechanical axis

⚙️ WHAT DOES THE STS-C ACTUALLY DO?

👉 This is where the level changes.

The STS does not simply “immobilize.”

🔴 IT ACTS ON:

✔ Vascular system → reduces bleeding
✔ Neurological system → decreases nerve irritation
✔ Muscular system → eliminates spasm
✔ Fascial system → indirectly reduces pressure
✔ Mechanical system → restores alignment

🧠 REAL MECHANISM OF ACTION

🔬 EFFECT 1 — ALIGNMENT

  • Restores femoral length
  • Reduces bone displacement

🩸 EFFECT 2 — INDIRECT HEMOSTASIS

  • Reduces intramuscular dead space
  • Decreases internal bleeding

👉 Supported by traction splint evidence:

🧠 EFFECT 3 — FUNCTIONAL NEUROPROTECTION

  • Reduces nerve traction
  • Decreases nociceptive stimulus

💪 EFFECT 4 — MUSCLE RELAXATION

  • Eliminates reflex spasm
  • Reduces metabolic demand

⚖️ EFFECT 5 — DISTAL PERFUSION IMPROVEMENT

  • Improves distal arterial flow
  • Reduces vascular compression

⚔️ OPERATIONAL VALIDATION (JSOM)

📄 Comparative evaluation

KEY RESULTS:

  • Faster application
  • Better control
  • Higher operator confidence
  • Superior overall performance

👉 Conclusion:

“Most suitable for battlefield use”

⚙️ DOCTRINAL COMPARISON (UPDATED)

🔴 STS vs HARE vs SAGER vs KTD

Parameter STS Hare Sager KTD
Type Proximal monopolar Bipolar classic Central bilateral Modular
Traction Hip-driven (push) Foot-driven (pull) Pelvic-based Foot-driven
Compactness ⭐⭐⭐⭐⭐ ⭐ ⭐ ⭐⭐⭐
Application time ⭐⭐⭐⭐⭐ ⭐⭐ ⭐ ⭐⭐⭐
Use in amputation ✅ ❌ ❌ ❌
Helicopter use ⭐⭐⭐⭐⭐ ⭐ ⭐ ⭐⭐
Complexity Low Medium High Medium

⚔️ REAL OPERATIONAL ANALYSIS

👉 STS solves three historical problems:

  1. Distal space dependency
  2. Logistical burden
  3. Complex trauma limitations

⚔️ TCCC INTEGRATION (MARCH)

🔴 M — Massive Hemorrhage

  • External bleeding control first (TQ if required)

🔴 C — Circulation

👉 STS role:

  • Reduces internal hemorrhage
  • Improves hemodynamic stability

🧠 CRITICAL ERRORS

❌ Applying traction before hemorrhage control
❌ Failure to assess distal pulses
❌ Failure to reassess neurological status

🔴 MANDATORY REASSESSMENT (POST-APPLICATION)

After STS placement:

✔ Distal pulse
✔ Capillary refill
✔ Sensory function
✔ Motor function
✔ Pain level

👉 If deterioration occurs → reduce traction

⚠️ COMPLICATIONS IF MISUSED

  • Distal ischemia
  • Nerve compression
  • Increased pain
  • Secondary vascular injury

🧠 EXPERT LEVEL — WHAT NO ONE TELLS YOU

👉 Traction splints are among the very few devices that:

  • Act on deep trauma physiology
  • Do not just stabilize — they modify the pathophysiological trajectory

👉 However:

⚠️ Improper application = real iatrogenic harm

🧾 FINAL VERDICT 2026

The STS-C is:

  • A real evolution, not marketing
  • Designed for modern warfare, EMS, and austere environments
  • A device with direct physiological impact

👤 PROFESSIONAL PROFILE — AUTHORITY

Dr. Ramón Alejandro Reyes Díaz, MD (DrRamonReyesMD ⚕️)

Physician specialized in:

  • Emergency Medicine and Trauma
  • Tactical Medicine (TACMED)
  • Austere and Remote Medicine
  • Aeromedical and Offshore Medicine

International instructor:

  • ATLS, PHTLS, ITLS
  • TCCC, TECC, TCC-LEFR

Operational experience in:

  • Elite military and law enforcement units
  • VIP protection medicine
  • Conflict zones (Iraq, Mali, Mozambique)

Independent international medical device evaluator:

  • No conflicts of interest
  • No commercial bias
  • Evidence-based and operationally grounded

🧠 FINAL POSITION

👉 This is NOT marketing
👉 This is a technical, clinical, and operational evaluation

📚 REFERENCES

🧠 FINAL OPERATOR STATEMENT

“A traction splint is not meant to immobilize a leg.
It is meant to prevent the patient from bleeding to death internally.”

🔴

Perfect. Vamos al siguiente nivel real.

⚔️ TCCC SOP — SLISHMAN TRACTION SPLINT (STS-C)

Tactical Standard Operating Procedure | MARCH Integration

Updated 2026 | By DrRamonReyesMD ⚕️

🧠 CONTEXT

This SOP is designed for:

  • TACMED operators
  • Special operations medics
  • Advanced EMS providers
  • Austere / remote medical environments

👉 Objective:

Apply STS-C correctly, fast, and without causing iatrogenic damage

🔴 STEP 0 — SCENE & TACTICAL CONTEXT

Before touching the patient:

✔ Scene safe (or tactically acceptable)
✔ Threat suppressed / controlled
✔ Casualty accessible

🔴 STEP 1 — MARCH: MASSIVE HEMORRHAGE

PRIORITY: BLEEDING FIRST

✔ Identify life-threatening hemorrhage
✔ Apply tourniquet (TQ) if needed

👉 Key principle:

❗ NO traction splint before hemorrhage control

🔴 STEP 2 — RAPID FEMUR ASSESSMENT

CLINICAL SIGNS:

  • Limb shortening
  • External rotation
  • Severe pain
  • Instability
  • Swelling (thigh compartment)

⚠️ RED FLAGS (DO NOT APPLY IMMEDIATELY)

  • Suspected pelvic fracture
  • Massive open fracture with uncontrolled bleeding
  • Absent distal pulse (must reassess carefully)

🔴 STEP 3 — BASELINE NEUROVASCULAR CHECK

Before STS:

✔ Distal pulse (dorsalis pedis / posterior tibial)
✔ Capillary refill
✔ Sensation
✔ Motor function

👉 Document mentally or verbally

🔴 STEP 4 — PREPARE STS-C

✔ Remove from pouch
✔ Extend telescopic shaft
✔ Prepare proximal strap
✔ Prepare distal attachment

🔴 STEP 5 — PROXIMAL ANCHOR (CRITICAL STEP)

👉 Place at:

  • Ischial / proximal thigh interface (inguinal region)

✔ Ensure:

  • Stable contact
  • No genital compression
  • No vascular compromise

🔴 STEP 6 — DISTAL FIXATION

✔ Secure around:

  • Lower leg (above ankle or calf depending on model application)

✔ Avoid:

  • Direct pressure over fracture site

🔴 STEP 7 — APPLY TRACTION (CONTROLLED)

⚠️ THIS IS THE CRITICAL MOMENT

👉 Apply traction gradually:

  • Slow
  • Controlled
  • Continuous

🎯 TARGET:

✔ Pain reduction
✔ Limb length restoration
✔ Improved alignment

❌ STOP IF:

  • Pain worsens
  • Resistance increases sharply
  • Neurovascular status deteriorates

🔴 STEP 8 — LOCK SYSTEM

✔ Secure traction cord
✔ Confirm no slippage
✔ Recheck mechanical stability

🔴 STEP 9 — SECONDARY NEUROVASCULAR ASSESSMENT

MANDATORY:

✔ Distal pulse
✔ Cap refill
✔ Sensation
✔ Motor

👉 Compare with baseline

🔴 STEP 10 — IMMOBILIZATION & PACKAGING

✔ Secure limb with additional straps
✔ Integrate into stretcher or evacuation system
✔ Protect from hypothermia

🔴 STEP 11 — CONTINUOUS MONITORING

Every 5–10 min:

✔ Pain
✔ Pulse
✔ Perfusion
✔ Consciousness

⚠️ CRITICAL ERRORS IN REAL OPERATIONS

❌ ERROR 1 — “FAST BUT WRONG”

  • Applying traction without assessment

❌ ERROR 2 — OVERTRACTION

  • Excess force → nerve & vascular damage

❌ ERROR 3 — IGNORING PAIN FEEDBACK

  • Pain increase = warning sign

❌ ERROR 4 — NO REASSESSMENT

  • Leads to missed ischemia

❌ ERROR 5 — USING STS IN WRONG INDICATION

  • Pelvic fracture mistaken as femur

🧠 ADVANCED OPERATOR INSIGHTS

🔴 WHEN STS CHANGES OUTCOME

  • Long evacuation times
  • Austere environments
  • Delayed surgical care
  • High-energy trauma

🔴 WHEN STS IS SECONDARY

  • Massive hemorrhage dominates
  • Polytrauma with airway compromise
  • Tactical evacuation under fire

⚔️ SPECIAL SCENARIOS

🪖 COMBAT / TACTICAL

✔ Use during Tactical Field Care
✔ Avoid during Care Under Fire unless essential

🚁 MEDEVAC

✔ Ideal due to compact design
✔ No distal extension interference

🏥 CIVIL EMS

✔ Use when transport time > 15–20 min
✔ Consider analgesia adjunct

🧾 FIELD CHECKLIST (REAL OPERATOR)

🔴 BEFORE

  • Bleeding controlled
  • Femur fracture suspected
  • Baseline neurovascular status

🔴 DURING

  • Correct anchor placement
  • Controlled traction
  • Continuous feedback

🔴 AFTER

  • Reassess neurovascular
  • Secure device
  • Monitor continuously

🧠 FINAL DOCTRINAL PRINCIPLE

“Traction is not force.
Traction is controlled physiology.”

🧾 FINAL VERDICT — OPERATIONAL

The STS-C is:

✔ A high-performance traction system
✔ Designed for real-world constraints
✔ Effective only in trained hands

🧠 FINAL STATEMENT

“The difference between saving a life and causing harm with a traction splint
is not the device.
It is the operator.”


 

🔬 SLISHMAN TRACTION SPLINT COMPACT (STS-C)

Technical specifications, engineering data, and operational details (ESP / ENG)

Updated 2026 | By DrRamonReyesMD ⚕️

🇺🇸  — TECHNICAL DATA AND ENGINEERING DETAILS

⚙️ TECHNICAL SPECIFICATIONS

  • Device type: Proximal monopolar traction splint
  • Mechanical principle: Longitudinal traction from proximal anchor (hip)
  • System design: Telescopic with progressive adjustment
  • Structural material: Aerospace-grade aluminum alloy + high-strength polymers
  • Traction system:
    • Coarse adjustment (telescopic extension)
    • Fine adjustment via cord with mechanical locking

📐 DIMENSIONS & WEIGHT

  • Collapsed length: ≈ 33 cm (13 in)
  • Extended length: ≈ 90–110 cm (patient-dependent)
  • Weight: ≈ 350–450 g (ultralight)

👉 Designed for:

  • Expanded IFAK integration
  • Tactical backpacks
  • Aeromedical kits

🧩 SYSTEM COMPONENTS

  1. Proximal anchor (ischial/inguinal interface)
  2. Central telescopic shaft
  3. Cord-based traction system
  4. Mechanical locking mechanism
  5. Distal fixation (calf/tibia)
  6. Rotational stabilization wrap

🔧 FUNCTIONAL ENGINEERING

🔴 FORCE VECTOR

  • Direction: proximal → distal
  • Type: controlled compression + traction
  • Outcome: femoral biomechanical realignment

🔬 TRACTION CONTROL

  • Progressive system prevents overtraction
  • Allows micro-adjustments during transport
  • Minimizes iatrogenic injury

🩻 MEDICAL COMPATIBILITY

  • Radiolucent: compatible with X-ray / CT
  • No removal required for imaging
  • Aeromedical evacuation compatible

🪖 TACTICAL FEATURES

  • No distal extension beyond foot
  • Low visual profile
  • Ideal for confined spaces
  • Functional in partial amputations

⚠️ OPERATIONAL LIMITATIONS

  • Does not replace hemorrhage control
  • Requires prior neurovascular assessment
  • Operator-dependent effectiveness

🧠 ENGINEERING + MEDICINE — INTEGRATED INTERPRETATION

👉 The STS-C combines:

  • Mechanical engineering (force vector control)
  • Physiology (bleeding + perfusion)
  • Neuroprotection (nerve tension reduction)

🧾 FINAL TECHNICAL VERDICT

The STS-C is:

✔ One of the most compact traction systems available
✔ Mechanically efficient with minimal components
✔ Optimized for real-world operational constraints

🧠 FINAL STATEMENT

“The value of the STS is not in its structure.
It is in how precisely it translates force into physiology.”

DrRamonReyesMD ⚕️
Emergency | Trauma | TACMED | Operational Medicine

🔬 SLISHMAN TRACTION SPLINT COMPACT (STS-C)

Self-Application & Operational Windows (Advanced Tactical Use)

Updated 2026 | By DrRamonReyesMD ⚕️

🧠 1. SELF-APPLICATION (CRITICAL CAPABILITY)

🔴 CONCEPT

The STS-C is one of the very few femoral traction systems with real-world self-application capability.

👉 This is not marketing.
It is a critical operational feature in:

  • Isolated operators
  • Hostile environments
  • Delayed medical response
  • Covert or low-profile missions

⚙️ WHY SELF-APPLICATION IS POSSIBLE

Three core design elements enable it:

1. 🔧 MONOPOLE STRUCTURE

  • No distal frame assembly required
  • No complex multi-component setup

2. 🎯 PROXIMAL TRACTION MECHANISM

  • Force control is located near the operator
  • Allows manipulation within limited reach

3. 🧩 INTEGRATED DESIGN

  • No loose parts
  • Linear, intuitive deployment sequence

🪖 REAL SELF-APPLICATION PROTOCOL

🔴 INITIAL POSITION

  • Supine or semi-seated
  • Injured limb accessible

🔴 STEPS

  1. Place proximal anchor in inguinal/ischial region
  2. Extend telescopic shaft with one hand
  3. Secure distal attachment at calf/lower leg
  4. Apply controlled progressive traction
  5. Lock the system

⚠️ REAL LIMITATIONS

❗ Only viable if:

  • Patient is conscious
  • No bilateral lower limb injuries
  • No advanced shock
  • No suspected pelvic fracture

❌ NOT REALISTIC IN:

  • Severe polytrauma
  • Loss of consciousness
  • Active massive hemorrhage
  • Tactical instability

🧠 TRUE VALUE

👉 Self-application is not routine.
👉 But when needed → it becomes a survival multiplier

🔴 2. OPERATIONAL WINDOWS (“WHEN TO APPLY”)

🧠 DEFINITION

Operational “windows” =
the correct tactical and physiological moment to apply STS

👉 Not just if, but when it makes sense

⚔️ OPERATIONAL CLASSIFICATION

🟢 WINDOW 1 — IDEAL (GOLD WINDOW)

✔ Tactical Field Care
✔ Hemorrhage controlled
✔ Patient conscious

👉 Maximum physiological benefit

🟡 WINDOW 2 — CONDITIONAL

✔ Prolonged evacuation
✔ Limited resources
✔ Severe pain

👉 Apply if:

  • Does not interfere with priorities
  • Improves stability

🔴 WINDOW 3 — DELAYED

✔ Immediate evacuation available
✔ Short transport time

👉 STS may be:

  • Deferred
  • Applied during transport

❌ WINDOW 4 — CONTRAINDICATED

🚫 Care Under Fire
🚫 Uncontrolled hemorrhage
🚫 Untreated shock
🚫 Suspected pelvic fracture

👉 Do NOT apply STS

🧠 DECISION MATRIX (REAL OPERATOR)

Scenario Apply STS
Active hemorrhage ❌ NO
Isolated femur fracture ✅ YES
Unstable polytrauma ⚠️ CONDITIONAL
Immediate extraction ❌ NO
Prolonged evacuation ✅ YES
Solo operator ⚠️ CONDITIONAL

⚠️ CRITICAL ERROR (COMMON)

❌ “Femur fracture → apply STS immediately”

👉 WRONG

✔ First:

  • MARCH algorithm
  • Hemorrhage control
  • Global assessment

👉 STS is optimization, not first-line priority

🧠 ADVANCED OPERATOR INSIGHT

👉 The difference is not knowing how to apply STS
👉 The difference is knowing when NOT to apply it

🔴 INTEGRATED REAL-WORLD VALUE

The STS-C stands out because:

✔ Enables self-application
✔ Fits real tactical windows
✔ Does not depend on ideal conditions

🧾 OPERATIONAL VERDICT

👉 The real value of the STS is not:

  • Its size
  • Its weight
  • Its appearance

👉 It is:

Its usability when everything else is failing

🧠 FINAL ELITE STATEMENT

“A great device works under perfect conditions.
A real device works when everything is going wrong.”

 

🔬 SLISHMAN TRACTION SPLINT COMPACT (STS-C)

Self-Application & Operational Windows (Advanced Tactical Use)

Updated 2026 | By DrRamonReyesMD ⚕️

🧠 1. SELF-APPLICATION (CRITICAL CAPABILITY)

🔴 CONCEPT

The STS-C is one of the very few femoral traction systems with real-world self-application capability.

👉 This is not marketing.
It is a critical operational feature in:

  • Isolated operators
  • Hostile environments
  • Delayed medical response
  • Covert or low-profile missions

⚙️ WHY SELF-APPLICATION IS POSSIBLE

Three core design elements enable it:

1. 🔧 MONOPOLE STRUCTURE

  • No distal frame assembly required
  • No complex multi-component setup

2. 🎯 PROXIMAL TRACTION MECHANISM

  • Force control is located near the operator
  • Allows manipulation within limited reach

3. 🧩 INTEGRATED DESIGN

  • No loose parts
  • Linear, intuitive deployment sequence

🪖 REAL SELF-APPLICATION PROTOCOL

🔴 INITIAL POSITION

  • Supine or semi-seated
  • Injured limb accessible

🔴 STEPS

  1. Place proximal anchor in inguinal/ischial region
  2. Extend telescopic shaft with one hand
  3. Secure distal attachment at calf/lower leg
  4. Apply controlled progressive traction
  5. Lock the system

⚠️ REAL LIMITATIONS

❗ Only viable if:

  • Patient is conscious
  • No bilateral lower limb injuries
  • No advanced shock
  • No suspected pelvic fracture

❌ NOT REALISTIC IN:

  • Severe polytrauma
  • Loss of consciousness
  • Active massive hemorrhage
  • Tactical instability

🧠 TRUE VALUE

👉 Self-application is not routine.
👉 But when needed → it becomes a survival multiplier

🔴 2. OPERATIONAL WINDOWS (“WHEN TO APPLY”)

🧠 DEFINITION

Operational “windows” =
the correct tactical and physiological moment to apply STS

👉 Not just if, but when it makes sense

⚔️ OPERATIONAL CLASSIFICATION

🟢 WINDOW 1 — IDEAL (GOLD WINDOW)

✔ Tactical Field Care
✔ Hemorrhage controlled
✔ Patient conscious

👉 Maximum physiological benefit

🟡 WINDOW 2 — CONDITIONAL

✔ Prolonged evacuation
✔ Limited resources
✔ Severe pain

👉 Apply if:

  • Does not interfere with priorities
  • Improves stability

🔴 WINDOW 3 — DELAYED

✔ Immediate evacuation available
✔ Short transport time

👉 STS may be:

  • Deferred
  • Applied during transport

❌ WINDOW 4 — CONTRAINDICATED

🚫 Care Under Fire
🚫 Uncontrolled hemorrhage
🚫 Untreated shock
🚫 Suspected pelvic fracture

👉 Do NOT apply STS

🧠 DECISION MATRIX (REAL OPERATOR)

Scenario Apply STS
Active hemorrhage ❌ NO
Isolated femur fracture ✅ YES
Unstable polytrauma ⚠️ CONDITIONAL
Immediate extraction ❌ NO
Prolonged evacuation ✅ YES
Solo operator ⚠️ CONDITIONAL

⚠️ CRITICAL ERROR (COMMON)

❌ “Femur fracture → apply STS immediately”

👉 WRONG

✔ First:

  • MARCH algorithm
  • Hemorrhage control
  • Global assessment

👉 STS is optimization, not first-line priority

🧠 ADVANCED OPERATOR INSIGHT

👉 The difference is not knowing how to apply STS
👉 The difference is knowing when NOT to apply it

🔴 INTEGRATED REAL-WORLD VALUE

The STS-C stands out because:

✔ Enables self-application
✔ Fits real tactical windows
✔ Does not depend on ideal conditions

🧾 OPERATIONAL VERDICT

👉 The real value of the STS is not:

  • Its size
  • Its weight
  • Its appearance

👉 It is:

Its usability when everything else is failing

🧠 FINAL ELITE STATEMENT

“A great device works under perfect conditions.
A real device works when everything is going wrong.”




Posted by at No hay comentarios:

Slishman Traction Splint tm by RESCUE ESSENTIALS


Slishman Traction Splint tm STS By Rescue Essentials

EMS Training | Femoral Traction Splinting with Dr. Sam Slishman. Inventor. 18 julio 2023 https://emssolutionsint.blogspot.com/2023/07/ems-training-femoral-traction-splinting.html #DrRamonReyesMD

Slishman Traction Splint tm Developer at EMSWORLD 2012

Slishman Traction Splint Training Video

Product Description and Benefits:
The STS was developed by Dr. Sam Slishman at the University of New Mexico to overcome many of the the design limitations of conventional traction splints. The innovative STS design has the traction mechanism positioned at the patient’s hip. Femur traction is applied through the extension of the pole segments creating a pushing force on the ankle strap instead of pulling distally from the foot. This innovative design change provides a number of outstanding benefits over conventional traction splints:

1. The STS Does Not Extend Beyond the Foot
    The traction splint stays anatomically contained from the patient's hip to ankle and  
    thus does not extend outside backboards, litters, and stretchers. This greatly reduces
    the risk of the splint being struck while extricating patients in space restrictive
    environments resulting in further injury to the patient.

2. Rapid Patient Application
    The unique design of the STS makes it the fastest splint to apply on the market. No poles
    to assemble or mechanisms to set up. When you need to immobilize the patient quickly
    for rapid extrication the STS won’t slow you down.

3. The STS is Not Contraindicated in Lower Leg Injury or Amputation
    While other traction splints are contraindicated with lower leg injury or amputation, the
    STS’s unique design allows the ankle strap to be alternately positioned proximal to
    the calf. This allows femur traction to still be applied and leaves the lower leg
    accessible for other splinting or bandaging.

4. Lightweight and Compact
    The STS weighs only 21 ounces and is 23” W x 3” H in size. It takes up little space
    in vehicles or aircrafts and can easily be strapped to trauma bags and backpacks. 

5. One Size Fits All
    The STS works with both adults and peds. No need to carry two different splints. If  
    your agency requires you to carry two traction splints, two STS splints can be
    carried for bi-lateral splinting.

6. Traction Mechanism Accessible During Transport
    If traction adjustment is needed while enroute, the STS traction adjustment is
    accessible at the patient’s hip, not jammed up against the door or airframe at the
    patient's foot.

7. Radiolucent

8. Lifetime Warranty

Dimensions: 23" W x 3" H x 3" D
Weight: 1.32 lbs
Slishman Traction Splint tm at EMSWORLD 2012


Slishman Traction Splint tm in Trauma Course, Dominican Republic


Official product web







Slishman Traction Splint tm at EMSWORLD 2012



AED Automatic External Defibrillator . UN compacto, economico y seguro https://emssolutionsint.blogspot.com/2019/08/aed-automatic-external-defibrillator-un.html

DESCARGA MANUAL PDF en Español 

Posted by at No hay comentarios:
Labels: , , , , , , ,
Suscribirse a: Entradas (Atom)